Skip to content

NEMAURA MEDICAL INC.: 10-K filed 2018-06-12

What NEMAURA MEDICAL INC. reported in its annual report filed 2018-06-12 (fiscal FY 2018): 35 published measures, 124 facts as tagged in accession 0001079973-18-000381.

This filing

Form
10-K (annual report)
Filed
2018-06-12
Fiscal period
fiscal FY 2018
Accession
0001079973-18-000381 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEMAURA MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-03-316,255,402USD
At 2017-03-317,401,906USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-03-312,144,437USD
At 2017-03-312,035,406USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-03-314,110,965USD
At 2017-03-315,366,500USD
At 2016-03-317,678,765USD
At 2015-03-31-917,411USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-03-31822,335USD
At 2017-03-31911,359USD
At 2016-03-319,403,965USD
At 2015-03-31354,749USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-01-01 to 2018-03-31-553,266USD90
2017-04-01 to 2018-03-31-1,820,449USD365
2017-10-01 to 2017-12-31-393,031USD92
2017-07-01 to 2017-09-30-466,365USD92
2017-04-01 to 2017-06-30-407,787USD91
2017-01-01 to 2017-03-31-359,235USD90
2016-04-01 to 2017-03-31-1,551,266USD365
2016-10-01 to 2016-12-31-375,366USD92
2016-07-01 to 2016-09-30-322,482USD92
2016-04-01 to 2016-06-30-494,183USD91
2015-04-01 to 2016-03-31-1,539,637USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-04-01 to 2018-03-31-2,136,977USD365
2016-04-01 to 2017-03-31-1,192,828USD365
2015-04-01 to 2016-03-31-1,209,365USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-04-01 to 2018-03-310USD365
2016-04-01 to 2017-03-316,519USD365
2015-04-01 to 2016-03-319,367USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-01-01 to 2018-03-310USD90
2017-04-01 to 2018-03-310USD365
2017-10-01 to 2017-12-310USD92
2017-07-01 to 2017-09-300USD92
2017-04-01 to 2017-06-300USD91
2017-01-01 to 2017-03-310USD90
2016-04-01 to 2017-03-310USD365
2016-10-01 to 2016-12-310USD92
2016-07-01 to 2016-09-300USD92
2016-04-01 to 2016-06-300USD91
2015-04-01 to 2016-03-310USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-04-01 to 2018-03-310USD365
2016-04-01 to 2017-03-310USD365
2015-04-01 to 2016-03-3110,299,434USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-04-01 to 2018-03-311,949,215USD365
2016-04-01 to 2017-03-31-6,306,089USD365
2015-04-01 to 2016-03-31-87,564USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-03-31-8,973,082USD
At 2017-03-31-7,152,633USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-01-01 to 2018-03-31150,070,400shares90
2017-04-01 to 2018-03-31150,070,400shares365
2017-10-01 to 2017-12-31205,000,000shares92
2017-07-01 to 2017-09-30121,411,478shares92
2017-04-01 to 2017-06-30205,000,000shares91
2017-01-01 to 2017-03-31205,000,000shares90
2016-04-01 to 2017-03-31205,000,000shares365
2016-10-01 to 2016-12-31205,000,000shares92
2016-07-01 to 2016-09-30205,000,000shares92
2016-04-01 to 2016-06-30205,000,000shares91
2015-04-01 to 2016-03-31201,726,027shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-04-01 to 2018-03-310USD365
2016-04-01 to 2017-03-310USD365
2015-04-01 to 2016-03-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-03-315,770USD
At 2017-03-319,161USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-03-31-567,776USD90
2017-04-01 to 2018-03-31-1,908,965USD365
2017-10-01 to 2017-12-31-447,516USD92
2017-07-01 to 2017-09-30-476,353USD92
2017-04-01 to 2017-06-30-417,320USD91
2017-01-01 to 2017-03-31-359,235USD90
2016-04-01 to 2017-03-31-1,551,266USD365
2016-10-01 to 2016-12-31-375,366USD92
2016-07-01 to 2016-09-30-322,482USD92
2016-04-01 to 2016-06-30-494,183USD91
2015-04-01 to 2016-03-31-1,539,637USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-03-315,998,533USD
At 2017-03-312,830,395USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-03-31811,309USD
At 2017-03-31852,371USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-03-3149,912USD
At 2017-03-3177,530USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-03-31251,099USD
At 2017-03-31203,800USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-04-01 to 2018-03-311,908,965USD365
2016-04-01 to 2017-03-311,551,266USD365
2015-04-01 to 2016-03-311,539,637USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-04-01 to 2018-03-31993,833USD365
2016-04-01 to 2017-03-311,034,605USD365
2015-04-01 to 2016-03-311,028,224USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-03-3167,676,000shares
At 2017-03-31205,000,000shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-03-31-40,625USD
At 2017-03-31-605,539USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2018-03-314,110,965USD
At 2017-03-315,366,500USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-03-3118,213USD
At 2017-03-3116,163USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-03-3112,443USD
At 2017-03-317,002USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-03-31256,869USD
At 2017-03-31212,961USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2018-03-310USD
At 2017-03-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-04-01 to 2018-03-31-1,820,449USD365
2016-04-01 to 2017-03-31-1,551,266USD365
2015-04-01 to 2016-03-31-1,539,637USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2017-04-01 to 2018-03-31-1,820,449USD365
2016-04-01 to 2017-03-31-1,551,266USD365
2015-04-01 to 2016-03-31-1,539,637USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-04-01 to 2018-03-31-1,255,535USD365
2016-04-01 to 2017-03-31-2,312,265USD365
2015-04-01 to 2016-03-31-1,403,824USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2018-03-31915,132USD365
2016-04-01 to 2017-03-31516,661USD365
2015-04-01 to 2016-03-31511,413USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-04-01 to 2018-03-3129,256USD365
2016-04-01 to 2017-03-3120,433USD365
2015-04-01 to 2016-03-3117,404USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-04-01 to 2018-03-310USD365
2016-04-01 to 2017-03-310USD365
2015-04-01 to 2016-03-3110,000,000USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-04-01 to 2018-03-31-31,247USD365
2016-04-01 to 2017-03-312,522USD365
2015-04-01 to 2016-03-31-31,279USD366

Inspect the source

Entity
NEMAURA MEDICAL INC. / CIK 0001602078
Captured
SEC response SHA-256
3af4f00449f095884d927b68ab2fc6d79dd5add77d667bb50f3822178e742afd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001602078.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))